Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Restructuring (2011)

Lemaitre Vascular (LMAT) reported Cash from Restructuring of -$7000.0 for Q4 2011, down 600.0% on a QoQ basis from -$1000.0 in Q3 2011.

Lemaitre Vascular (LMAT) has 1 years of Cash from Restructuring data on file, last reported at -$7000.0 in Q4 2011.

  • Quarterly Cash from Restructuring changed N/A year-over-year to -$7000.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was -$732000.0 (changed N/A YoY) and the FY2011 annual result came in at -$732000.0, down 577.78% from the prior year.
  • Cash from Restructuring retreated to -$7000.0 in Q4 2011 per LMAT's latest filing, from -$1000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at -$1000.0 in Q3 2011 and bottomed at -$709000.0 in Q1 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -7,000.00
Sep 30, 2011 -1,000.00
Jun 30, 2011 -15,000.00
Mar 31, 2011 -709,000.00